Keyphrases
Chronic Myeloid Leukemia
100%
MicroRNA-155 (miR-155)
100%
MicroRNA
100%
Myeloid Leukemia Cells
100%
MiR-31
100%
Signaling Pathway
14%
Molecular Pathways
14%
Leukemia Cell Lines
14%
Gene Expression
7%
Vascular Endothelial Growth Factor
7%
Expression Pattern
7%
Molecular Mechanism
7%
Complexity Level
7%
Cancer Development
7%
Role in Cancer
7%
Therapeutic Treatment
7%
MiRNA Expression
7%
Quantitative PCR
7%
Gene Pathway
7%
MicroRNA Profile
7%
Gene Signature
7%
MiRNA Microarray
7%
Disease-associated
7%
Control Genes
7%
ErbB
7%
Cancer Progression
7%
K562 Cells
7%
MiRNA Target
7%
Gene Targeting
7%
Venn Diagram
7%
Predicted Targets
7%
Mammalian Target of Rapamycin (mTOR)
7%
Non-coding
7%
Regulatory RNA
7%
BCR-ABL
7%
Potential Target Genes
7%
Targeted Regulation
7%
Target Selection
7%
Medicine and Dentistry
microRNA 155
100%
microRNA
100%
Downregulation
100%
Chronic Myelogenous Leukemia
100%
Leukemia Cell
100%
microRNA 31
100%
Disease
11%
Signal Transduction
11%
Chronic Myeloid Leukemia Cell Line
11%
Malignant Neoplasm
5%
Mitogen-Activated Protein Kinase
5%
Gene Expression
5%
Real Time Polymerase Chain Reaction
5%
Vasculotropin
5%
Mechanistic Target of Rapamycin
5%
K562 Cells
5%
ErbB
5%
Biochemistry, Genetics and Molecular Biology
Downregulation
100%
MicroRNA
100%
MiR-155
100%
Myeloid
100%
Mir-31
100%
Signal Transduction
11%
Mitogen-Activated Protein Kinase
5%
RNA
5%
Real-Time Polymerase Chain Reaction
5%
Microarrays
5%
Vascular Endothelial Growth Factor
5%
Candidate Gene
5%
ErbB
5%
K562 Cells
5%
Mechanistic Target of Rapamycin
5%
Gene Expression Control
5%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Myeloid Leukemia
100%
microRNA
100%
microRNA 155
100%
microRNA 31
100%
Disease
11%
Malignant Neoplasm
5%
Vasculotropin
5%
Mammalian Target of Rapamycin
5%
Immunology and Microbiology
Downregulation
100%
Leukemia Cell
100%
Myeloid
100%
Signal Transduction
25%
Chronic Myeloid Leukemia Cell Line
25%
Gene Expression
12%
Sirolimus
12%
Real Time Polymerase Chain Reaction
12%
Vasculotropin
12%